• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA

    2019-02-12 12:58:34LucieBeneovTerezalkovRenataPtkovAnastasiyaSemyakinaKateinaMenclovJiPudilMiroslavRyskaMiroslavLevJaromimFilipPazdrekJiHochMilanBlahaMarekMinrik
    World Journal of Gastroenterology 2019年48期

    Lucie Bene?ová, Tereza Hálková, Renata Ptá?ková, Anastasiya Semyakina, Kate?ina Menclová, Ji?í Pudil,Miroslav Ryska, Miroslav Levy, Jaromír ?im?a, Filip Pazdírek, Ji?í Hoch, Milan Blaha, Marek Minárik

    Abstract

    Key words: Circulating tumor DNA; Metastatic colorectal cancer; Postoperative;Radicality of resection; Follow-up; Recurrence

    INTRODUCTION

    Around 50% of patients with colorectal cancer (CRC) are found to have synchronous liver or extrahepatic metastases at the time of diagnosis or will develop metachronous metastases within several years after surgery[1]. It is known that radical surgical resection - the R0 resection which involves a complete removal of the diseased tissue -is the only effective treatment option, ideally in combination with perioperative chemotherapy[2]. The 5-year survival rate for patients with surgical treatment ranges from 41% to over 70% compared to 5% if not treated[3-5].

    Besides removal of metastases, postoperative patient follow-up is no less important as it allows for the timely identification of any progression or recurrence of the disease and prompt therapeutical response - whether by surgery or modification of systematic therapy. The monitoring of patients with metastatic CRC is predominantly based on imaging techniques such as ultrasonography (US), computed tomography(CT), positron emission tomography (PET), magnetic resonance imaging (MRI) or X-ray imaging (XRAY), usually with assessments of serum tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9). Nowadays,molecular biology techniques also play an irreplaceable role in the management of patients with CRC, considering that the decisions on cancer therapy are ever more supported by the knowledge of biological characteristics and genetic profile of the disease[6]. Most recently, the possibility for disease follow-up using circulating tumor DNA (ctDNA) has become available in addition to already implemented mutation profiling from tissue biopsies or resecates[7,8].

    The term ctDNA means short fragmented DNA, which has historically been observed in blood circulation of patients suffering with metastatic stages of cancers[9,10]. ctDNA is often referred to as cell-free DNA to emphasize its exogenous nature in comparison to DNA originating from nuclei of the blood cells. Although the exact mechanism of its release into circulation is still subject to debate, there are several probable mechanisms of the ctDNA origin including: Apoptosis; necrosis;active release through lipoproteonucleotidic complexes (virtosomes); phagocytosis;and exocytosis[11]. Due to its exclusive origin in cancerous cells, ctDNA retains the fundamental imprint of its cancer genome including cancer-specific aberrations such as somatic mutations. Therefore, the ctDNA analysis has recently been promoted using the term “l(fā)iquid biopsy”[12]. The main advantage of liquid biopsy, compared to the “classic” biopsy of tumor tissues is its minimal invasiveness and the associated minimal stress for the patient. Additionally, ctDNA is released to the bloodstream from all tumor foci, and thus a single blood sample contains the complete mutation spectrum of cancer clones present in the patient's body[13].

    Besides liquid biopsy, ctDNA testing has proven to be a very promising instrument for long-term, postoperative follow-ups of patients with CRC, particularly in advanced stages. Being minimally invasive, it can be repeated over short periods for a long time with no significant burden to the patient, and moreover, this test shows high sensitivity and specificity to patients with preoperative ctDNA positivity[14]. The approach fundamentally relies on the applied methodology, which must be able to capture < 0.1% of ctDNA on the background of non-tumor DNA. Accordingly, the current techniques include dedicated approaches such as those based on digital PCR,BEAMing or deep sequencing[15]. In all cases, tumor-specific DNA alterations (usually mutations) found in the tumor tissue or occurring with a certain significant frequency in the given cancer are used as ctDNA positivity markers. However, the above mentioned methods have their limitations, particularly in terms of higher demands on the input DNA amount and the costs. Another sensitive, efficient, rapid and affordable method based on the formation of heteroduplexes with subsequent detection using denaturing capillary electrophoresis (DCE) has been used at our center for 10 years. This method can be used to detect a mutated locus in plasma with the sensitivity of 0.03% to 1% depending on the mutation to be determined (Table 1)with input DNA amount of tens of pg[16,17]. The specificity of this ctDNA test is 100%,which means that the presence of ctDNA always provides evidence that a tumor residue or tumor cells are present. As previously shown by us, ctDNA testing using DCE allows patient follow-up in real time, while ctDNA levels correlate very well with the current condition of the patient[17]. As we reported in this paper about a group of patients with metastatic CRC, ctDNA can be used in clinical practice,particularly for the evaluation of the radicality of surgery and for the timely detection of any progression or recurrence of the disease.

    MATERIALS AND METHODS

    Patients and samples

    This study was conducted in cooperation with three prime surgery centers in the Czech Republic in accordance with the Declaration of Helsinki and was approved by ethics committees of the relevant hospitals. The forty-seven patients enrolled in the study had undergone the resection of synchronous or metachronous colorectal cancer metastases and tested positive for ctDNA before surgery, and were thus suitable candidates for postoperative ctDNA follow-up. Patient characteristics are listed in Table 2. All patients signed an informed consent form for the study. A tumor tissue sample was surgically obtained in each case. Peripheral blood samples for ctDNA analysis were collected in an anticoagulant solution before, 1 week after the surgery,and subsequently in several-month intervals during their follow-ups. Clinical patient data including tumor localization and type, surgical radicality, and CEA and CA 19-9 marker levels were also collected.

    Table 1 Characteristics of the markers used for the mutation analysis[16,17]

    DNA isolation and detection of mutations

    Mutation profiles were determined in DNA isolated from tumor tissues,subsequently, the detected mutations were analyzed in plasma samples. Tumor DNA was isolated from the samples of native frozen (-20 °C) tissues using the GenElute?Mammalian Genomic DNA Miniprep Kit (Sigma Aldrich, St. Louis, MS, United States). ctDNA was isolated using the NucleoSpin Plasma XS (Macherey-Nagel,Dueren, Germany) from plasma according to the instructions of the manufacturer.Plasma was obtained by centrifugation of blood promptly after collection, and then immediately frozen at -20 °C. The mutations were identified using a panel for the detection of the most commonly mutated loci in theKRAS,TP53,APC,PIK3CA,BRAFandCTNNB1genes, which are characteristic for colorectal cancer (see Table 1 for details). Tumor tissue and ctDNA mutations were detected using PCR with the formation of heteroduplexes and subsequent separation using DCE. The principle of the method has been described previously[18].

    Resection radicality and recurrence of the disease

    The radicality of surgical removal of colorectal cancer metastases was determined by the pathologist based on examination of the resected samples' margins. Complete resections with no macroscopic or microscopic tumor residues were identified as R0.For R0 resections, the minimum distance of tumor cells from the resection line was > 0 mm. Microscopically incomplete resections, with a presence of tumor cells in the margin detected by the pathologist, were identified as R1. Macroscopically incomplete resections were identified as R2 and were classified as R2a (macroscopic presence of a residue of the primary tumor), R2b (macroscopic presence of distal metastases), R2c(macroscopic presence of any residue(s) of the primary tumor as well as of distal metastases)[19]. The surgical radicality assessments were supplemented with an analysis of postoperative ctDNA.

    Disease recurrence was longitudinally monitored and was assessed using imaging methods (most commonly CT, MRI, US, XRAY) and using CEA (normal levels ≤ 5 ng/mL) and CA19-9 (normal levels ≤ 37 U/mL) tumor marker levels. Any abnormalities detected by imaging techniques or elevated levels of at least one tumor marker were considered recurrences. This data were correlated with the presence of ctDNA. The ctDNA was evaluated until recurrence or during the patient's follow-up period.

    Table 2 Clinical patient data

    RESULTS

    Detailed information on the 47 patients enrolled in the study is available in Supplementary Table 1. In total, 79 tumor tissue samples (25 from the primary tumor, 6 from lymph nodes and 48 from distal metastases) and 202 plasma samples (51 before surgery, 39 after surgery and 112 during follow-up) were collected over the course of the study. A detailed overview of the collected samples and mutations detected in tumor tissue is provided in Supplementary Table 2.

    Sixty-three resections were done during the study (including repeated resections during follow-up), which comprised 40 R0, 7 R1 and 16 R2 resections. A postoperative ctDNA sample to assess the correlation of ctDNA and surgery radicality was available for 39 patients undergoing 50 surgeries (28 R0, 7 R1 and 15 R2) (Table 3; for detailed information see Supplementary Table 1). Among the 28 cases of R0 resection,postoperative ctDNA tested negative in 26 cases (26/28, 93%). After the first of the two remaining R0 surgeries, a RFA of a small metastasis in the liver, the patient continued displaying ctDNA and, subsequently, was diagnosed with disease recurrence within the scar 6 mo after the surgery. The second case of ctDNA positivity after R0 surgery was a right-sided hemicolectomy with metastasectomy. Also, in this case, the recurrence (two new liver metastases) was visibleviaimaging methods 6 months after the surgery.

    In 7 cases with R1 resection, postoperative ctDNA was positive 4 times (4/7, 57%)with disease recurrence 3, 3, 4 and 7 mo after surgery in these cases. For the remaining 3 patients with negative ctDNA after R1 surgery (3/7, 43%), two of them had postoperative recurrence after 7 or 22 mo, and the third one has gone 5 months with no recurrence after surgery. Postoperative ctDNA was positive in all 15 patients with R2 resection (15/15, 100%).

    Postoperative tumor recurrence was evaluated according to positive results of ctDNA testing, imaging methods and tumor marker assessments. In our set of 32patients undergoing R0 resections of liver metastases and long-term postoperative monitoring, 22 patients had recurrences (22/32, 69%, see Supplementary Table 1). In 17 patients, from whom all parameters for the detection of postoperative tumor recurrence were available, a total of 22 recurrences were confirmed (3 patients had repeated recurrences - 2 and 4 recurrences). Thirteen times (13/22, 59%) the recurrence was simultaneously detected by ctDNA, imaging methods and tumor markers. Seven times (7/22, 32%) the tumor markers were negative and 6 times (6/22,27%) the imaging methods were without evidence of tumor. The ctDNA was not negative even once (0/22, 0%), making ctDNA in our study the most sensitive tool for detecting tumor recurrence of all three methods. In four patients (4/22, 18%) the tumor recurrence was detected by ctDNA only, while imaging methods and tumor markers were negative (Table 4).

    Table 3 Correlation of surgical radicality and postoperative circulating tumor DNA

    DISCUSSION

    Radicality of surgery is normally assessed based on histological examination of a resected sample and based on the results of imaging methods. However, these examinations cannot indicate any potential presence of circulating tumor cells found in the bloodstream or lymphatic pathways due to a metastatic process or dissemination during surgery. Potential presence of microscopic metastases cannot be demonstrated using histology or imaging methods either. Although the follow-up of tumor marker levels may be useful for detection, their sensitivity and specificity are low[20]. ctDNA is a highly dynamic marker with an approximate half-life of 2 hours,and its levels correspond to the clinical condition of patients with mCRC[17,21]. As we have shown in this paper, a postoperative presence of ctDNA correlates very well with surgery radicality, and its elevated levels in R0 and R1 resections may signal the occurrence of micrometastases and thus help to identify patients with an increased risk of early recurrence for a higher frequency of their follow-up assessments or for an indication of adjuvant therapy[22-24].

    To date, only three papers have been published studying the presence of ctDNA immediately after CRC resection. One study in 2005 focused onKRASmutation persistence in the plasma of patients with colorectal cancer in various stages 3 days from radical surgery. As surprisingly indicated by the results, most patients with preoperatively detectedKRASmutations in plasma had the same mutations detected in plasma, also 3 days from radical surgery (7/9, 78%). Only two patients had no mutation detected in the postoperative period (2/9, 22%)[25]. As mentioned in another study, ctDNA can provide information on radicality of primary resection of colorectal cancer, which was illustrated in the case of a patient where evidence of insufficient radicality of the primary surgery was provided based on the presence of postoperative ctDNA[26]. The last study from 2016 showed a correlation between R0 resections and postoperative ctDNA negativity in 75% of patients (6/8) and a correlation between R2 resection and postoperative ctDNA positivity in 67% of patients (2/3), by presenting a set of 11 patients with preoperatively positive ctDNA results, undergoing R0 (8 times) or R2 (3 times) resection[27].

    Compared to the above mentioned studies, our study presents the largest group of patients so far with preoperatively detected ctDNA (47 in total) in whom postoperative ctDNA correlation with surgery radicality was followed, and this studyis also the first to report ctDNA correlation with R1 resection. In our group of patients who underwent R1 resections, more than half of them were postoperative ctDNA positive. Considering that in these patients, only a small number of tumor cells were present in the resection margin that they are unlikely to release their DNA into the bloodstream, ctDNA positivity could indicate that there are still other micrometastases not detected by imaging methods. This corresponds to significantly shorter times without recurrence (3, 3, 4 and 7 mo) compared to patients with negative postoperative ctDNA (7 and 22 mo). The presence of micrometastases was also probably recognized in two postoperative ctDNA-positive patients undergoing R0 resection, as their time to recurrence was also very short (6 mo both) when compared to patients with negative R0 postoperative ctDNA (14 times recurrence after 4-22 mo, 10 times no recurrence in surveillance 6-36 mo). Unlike other studies,postoperative ctDNA positivity was captured in all R2 resections (15/15, 100%) in our study, which may be due to the sensitivity of the used detection methods. Our DCE method provides the limit of detection (LOD) of 0.03%-1% (see Table 1), while the studies referred to above used the Temperature Gradient Gel Electrophoresis method with LOD 1%-5%[28]and the Quantitative Polymerase Chain Reaction assay based on allele-specific PCR with LOD 1%-2%[29].

    Table 4 Comparison of circulating tumor DNA and standard detection methods

    Liver metastatic recurrence occurs in approximately 50% of patients undergoing hepatectomy, while 12% have a recurrence more than once. Considering that repeated hepatectomy combined with systemic therapy may improve overall survival of these patients[30-32], efficient follow-ups for the early detection of recurrence is very important[33].

    Tumor markers are commonly used for follow-ups, but so far cannot be used alone to diagnose recurrence, and imaging methods sometimes do not recognize small foci(micrometastases) or, on the contrary, find abnormalities that are not cancer.Examination of ctDNA could be another tool used during follow-up. Our detection method enables high reliability testing (the false positive probability of ctDNA is 0%).In our 22 cases of postoperative tumor recurrence imaging methods and tumor marker results detected a recurrence in 16/22 (73%) and 15/22 (68%) cases,respectively, ctDNA was present in 22/22 (100%) cases. Our results are consistent with the findings of several similar studies that have been performed on a comparable or smaller number of samples[24,26,34-36]. Therefore, we consider our set of 22 recurrences after curative (R0) surgical treatment recorded in our study as adequate to confirm utility of the ctDNA test as a viable tool for the early detection of mCRC recurrence.

    Compared to our overall ctDNA detection rate in patients with advanced CRC at the time of the diagnosis (55%-75%), the detection rate in patients previously tested positive for ctDNA is much higher. This data indicates that although the ctDNA release rate into the bloodstream due to the presence of tumor foci differs in various patients with mCRC, for each given patient this phenomenon is relatively stable; thus if ctDNA is detectable in the body when tumor foci are present, it is highly probable that after their complete removal and subsequent recurrence, ctDNA will be detected again.

    Although ctDNA detection cannot replace traditional methods used in the followup scheme, it might be a useful supplementary instrument for both the prediction and earlier detection of recurrences, particularly in patients with a higher risk of liver metastatic recurrence[37], and thus it may actually improve the overall survival odds of such patients.

    ARTICLE HIGHLIGHTS

    extrahepatic metastases at the time of diagnosis, or will develop metachronous metastases within several years after surgery. It is known that radical surgical resection, the R0 resection which involves a complete removal of the diseased tissue, is the only effective treatment option, ideally in combination with perioperative chemotherapy. Besides removal of colorectal cancer metastases, postoperative patient follow-up is no less important as it allows for the timely identification of any progression or recurrence of the disease and prompt therapeutical response.The monitoring of patients is predominantly based on imaging techniques, usually with assessments of serum tumor markers. One of the promising tools for long-term postoperative follow-up is the detection of circulating tumor DNA (ctDNA) in the peripheral blood. Sometimes referred to as a "liquid (re)biopsy" it is a minimally invasive procedure and can be performed repeatedly at relatively short intervals (months or even weeks). The presence of the disease and the actual extent of the tumor burden (tumor mass) within the patient's body can be monitored.This is of particular importance, especially when evaluating radicality of surgical treatment as well as for early detection of disease progression or recurrence.

    Research motivation

    Radicality of surgery is normally assessed using histological examination of a resected sample and based on the results of imaging methods. However, these examinations cannot indicate any potential presence of circulating tumor cells or microscopic metastases. Also, the main tools used for postoperative patient follow-up, imaging methods and tumor markers, are often not sufficient in early detection of disease progression or recurrence. Tumor markers have low specificity and sensitivity so that they cannot be used alone to diagnose recurrence. Imaging methods are known to fail to detect small foci (micrometastases) or, on the contrary, find abnormalities that are not cancer. Moreover, they cannot be performed frequently due to the radiation exposure. The recently introduced ctDNA testing could present a useful alternative tool. It has proven to be very promising for long-term, postoperative follow-ups of patients with CRC, particularly in advanced stages. Being minimally invasive, it can be repeated frequently for a long time with no significant burden to the patient, and moreover, this test shows high sensitivity and specificity to patients with preoperative ctDNA positivity.

    Research objectives

    The main objectives of the study were to confirm the radicality of surgery using ctDNA and to compare available methods for detection of recurrence in metastatic CRC (mCRC). It is important to verify whether ctDNA can be used in clinical practice, particularly for the evaluation of the radicality of surgery and for the timely detection of any progression or recurrence of the disease.

    Research methods

    A total of 47 patients with detected ctDNA and indications for resection of mCRC were enrolled in the multicenter study involving three surgical centers. Standard postoperative follow-ups using imaging techniques and the determination of tumor markers were supplemented by ctDNA sampling. In addition to the baseline ctDNA testing prior to surgery, a postoperative observation was conducted by evaluating ctDNA presence up to a week after surgery and subsequently at approximately three-month intervals. The presence of ctDNA was correlated with radicality of surgical treatment and the actual clinical status of the patient. To test ctDNA,we performed a sensitive, efficient, rapid and affordable method based on the formation of heteroduplexes with subsequent detection using denaturing capillary electrophoresis (DCE).This method can be used to detect a mutated locus in plasma with the sensitivity of 0.03% to 1%depending on the mutation to be determined with input DNA amount of tens of pg. The specificity of this ctDNA test is 100%, which means that the presence of ctDNA always provides evidence that a tumor residue or tumor cells are present. As previously shown by us, ctDNA testing using DCE allows a patient follow-up in real time, while ctDNA levels correlate very well with the current condition of the patient.

    Research results

    Among the monitored patients, the R0 (curative) resection correlated with postoperative ctDNA negativity in 26 out of 28 cases of surgical procedures (93%). In the remaining cases of R0 surgeries that displayed ctDNA, both patients were diagnosed with a recurrence of the disease after 6 mo. In 7 patients who underwent an R1 resection, 4 ctDNA positivities (57%) were detected after surgery and associated with the confirmation of early disease recurrence (after 3-7 mo). All 15 patients undergoing R2 resection remained constantly ctDNA positive during the entire follow-up period. In 22 cases of recurrence, ctDNA positivity was detected 22 times (100%)compared to 16 positives (73%) by imaging methods and 15 cases (68%) of elevated tumor markers.

    Research conclusions

    Although ctDNA detection cannot replace traditional methods used in the follow-up scheme, it might represent a useful supplementary instrument for both the prediction and earlier detection of recurrences, particularly in patients with a higher risk of liver metastatic recurrence, and thus it may actually improve the overall survival odds of such patients. And it has also been shown that the ctDNA test is a highly specific and sensitive tool for confirming the radicality of surgical treatment and for the potential prediction of early disease recurrence after R0/R1 surgeries.

    Research perspectives

    In this study, the high sensitivity of the methodology used to test ctDNA after curative mCRC surgical treatment and also to detect recurrence of the disease was shown. However, to confirm this hypothesis, testing on a larger sample set is required. In particular, it is desirable to obtain a greater number of ctDNA positive and negative results after R1 resections that could be correlated with time to disease recurrence. Similarly, expanding the set of long-term follow-up patients using standard approaches supplemented with ctDNA sampling is warranted.

    午夜精品一区二区三区免费看| 欧美高清性xxxxhd video| 国产高清三级在线| 床上黄色一级片| 在线a可以看的网站| 99热这里只有是精品在线观看 | 草草在线视频免费看| 波多野结衣巨乳人妻| 日韩欧美 国产精品| 一级黄片播放器| 丝袜美腿在线中文| 丁香欧美五月| 久久午夜福利片| 黄色一级大片看看| 亚洲不卡免费看| 成人av在线播放网站| 变态另类丝袜制服| 亚洲中文字幕日韩| 夜夜躁狠狠躁天天躁| 免费观看的影片在线观看| 久久人人爽人人爽人人片va | 国产人妻一区二区三区在| 久久久精品欧美日韩精品| 国产三级中文精品| 亚洲午夜理论影院| 亚洲成人久久爱视频| 国产精品一区二区三区四区久久| 精品一区二区三区视频在线观看免费| 日本在线视频免费播放| 51午夜福利影视在线观看| 久久婷婷人人爽人人干人人爱| 日韩国内少妇激情av| 亚洲三级黄色毛片| 婷婷丁香在线五月| 可以在线观看的亚洲视频| 亚洲国产精品成人综合色| 免费高清视频大片| 人人妻,人人澡人人爽秒播| av黄色大香蕉| 欧美激情在线99| 精品乱码久久久久久99久播| 97碰自拍视频| 国产精品亚洲一级av第二区| 日日夜夜操网爽| 亚洲欧美精品综合久久99| 日本一二三区视频观看| 噜噜噜噜噜久久久久久91| 97超视频在线观看视频| 欧美+亚洲+日韩+国产| 亚洲无线观看免费| av黄色大香蕉| 亚洲国产色片| 日韩av在线大香蕉| 欧美又色又爽又黄视频| 在线观看免费视频日本深夜| 色综合婷婷激情| 精品人妻一区二区三区麻豆 | 欧美日韩黄片免| 老女人水多毛片| 久久99热6这里只有精品| 国产成人aa在线观看| 欧美zozozo另类| 九九久久精品国产亚洲av麻豆| 网址你懂的国产日韩在线| 搡老熟女国产l中国老女人| 最近最新免费中文字幕在线| 久久人人精品亚洲av| av在线老鸭窝| 精品一区二区三区视频在线| 综合色av麻豆| 久久99热这里只有精品18| 又粗又爽又猛毛片免费看| 一区二区三区激情视频| 亚洲国产高清在线一区二区三| 在线观看66精品国产| 日韩国内少妇激情av| 一本综合久久免费| 搡老熟女国产l中国老女人| 午夜视频国产福利| 精品久久久久久久人妻蜜臀av| 怎么达到女性高潮| 欧美潮喷喷水| 国产精品不卡视频一区二区 | 国产蜜桃级精品一区二区三区| 少妇人妻一区二区三区视频| 亚洲精品亚洲一区二区| 最好的美女福利视频网| 亚洲自拍偷在线| av中文乱码字幕在线| 午夜影院日韩av| 日本与韩国留学比较| 一级a爱片免费观看的视频| 婷婷色综合大香蕉| 91av网一区二区| 一区福利在线观看| 少妇丰满av| 他把我摸到了高潮在线观看| 草草在线视频免费看| 99热只有精品国产| 女生性感内裤真人,穿戴方法视频| www.999成人在线观看| a级毛片免费高清观看在线播放| 黄色视频,在线免费观看| 亚洲av日韩精品久久久久久密| 51午夜福利影视在线观看| 午夜老司机福利剧场| 午夜激情欧美在线| 国产精品亚洲av一区麻豆| 国产久久久一区二区三区| 亚洲欧美日韩高清在线视频| 午夜视频国产福利| 看十八女毛片水多多多| 日本黄大片高清| 在线观看av片永久免费下载| 97人妻精品一区二区三区麻豆| 国产高清激情床上av| 97超视频在线观看视频| 亚洲无线在线观看| 天美传媒精品一区二区| 欧美成人一区二区免费高清观看| 午夜激情欧美在线| 成人亚洲精品av一区二区| 亚洲第一欧美日韩一区二区三区| 男人狂女人下面高潮的视频| 国产v大片淫在线免费观看| 亚洲人成网站高清观看| 在线国产一区二区在线| 欧美激情久久久久久爽电影| 国产大屁股一区二区在线视频| 十八禁国产超污无遮挡网站| 麻豆av噜噜一区二区三区| 别揉我奶头 嗯啊视频| 99热精品在线国产| 国产午夜精品论理片| 亚洲经典国产精华液单 | 91在线精品国自产拍蜜月| 最后的刺客免费高清国语| av女优亚洲男人天堂| bbb黄色大片| 内地一区二区视频在线| 啦啦啦观看免费观看视频高清| 国产成人a区在线观看| 国产伦一二天堂av在线观看| 久久久久免费精品人妻一区二区| 欧美绝顶高潮抽搐喷水| 熟女电影av网| 中文字幕av成人在线电影| av中文乱码字幕在线| 中文字幕av成人在线电影| 欧美bdsm另类| 日韩欧美三级三区| 噜噜噜噜噜久久久久久91| 一区二区三区四区激情视频 | 久久久久国内视频| 在线看三级毛片| 亚洲avbb在线观看| 亚洲av成人精品一区久久| 午夜视频国产福利| 日韩国内少妇激情av| 国产精品1区2区在线观看.| 欧美区成人在线视频| 日韩精品青青久久久久久| eeuss影院久久| 少妇的逼好多水| 成人特级av手机在线观看| 一个人免费在线观看电影| 亚洲欧美日韩卡通动漫| 男人的好看免费观看在线视频| 午夜福利在线观看吧| 99在线视频只有这里精品首页| 99热6这里只有精品| 高清在线国产一区| 窝窝影院91人妻| 少妇熟女aⅴ在线视频| 久久国产精品影院| 国产精品一区二区性色av| 精品久久久久久,| 亚洲av成人av| 深爱激情五月婷婷| 久久久久国内视频| 欧美xxxx性猛交bbbb| 高清在线国产一区| 欧美绝顶高潮抽搐喷水| 亚洲成人久久性| 国产午夜精品久久久久久一区二区三区 | 美女 人体艺术 gogo| 欧美色欧美亚洲另类二区| 老司机午夜福利在线观看视频| 中文字幕人妻熟人妻熟丝袜美| 淫妇啪啪啪对白视频| 特级一级黄色大片| 亚洲电影在线观看av| av天堂在线播放| 91麻豆精品激情在线观看国产| 国产精品日韩av在线免费观看| 最近最新免费中文字幕在线| 亚洲人成伊人成综合网2020| 国产色婷婷99| 91九色精品人成在线观看| 国产一区二区三区视频了| 久久亚洲精品不卡| 哪里可以看免费的av片| 一个人观看的视频www高清免费观看| 中文字幕精品亚洲无线码一区| 欧洲精品卡2卡3卡4卡5卡区| 国产精品电影一区二区三区| 国产精品1区2区在线观看.| 亚洲欧美日韩无卡精品| 波多野结衣高清作品| 亚洲欧美日韩卡通动漫| 国内精品久久久久久久电影| 99久久成人亚洲精品观看| 真人做人爱边吃奶动态| 精品不卡国产一区二区三区| 精品久久久久久久久亚洲 | 欧美午夜高清在线| 极品教师在线免费播放| 给我免费播放毛片高清在线观看| 性欧美人与动物交配| 成人欧美大片| 变态另类成人亚洲欧美熟女| 日本与韩国留学比较| 天堂√8在线中文| 成年人黄色毛片网站| 97超级碰碰碰精品色视频在线观看| 黄色丝袜av网址大全| 99久久99久久久精品蜜桃| 熟女电影av网| 村上凉子中文字幕在线| 国产91精品成人一区二区三区| a级毛片免费高清观看在线播放| 99riav亚洲国产免费| 色综合欧美亚洲国产小说| 亚洲国产日韩欧美精品在线观看| 亚洲av五月六月丁香网| 欧美精品啪啪一区二区三区| 日韩免费av在线播放| 日韩免费av在线播放| 国产成年人精品一区二区| 一夜夜www| 最新在线观看一区二区三区| 看片在线看免费视频| 免费av不卡在线播放| 美女免费视频网站| 免费观看人在逋| 国产美女午夜福利| 观看免费一级毛片| 亚洲va日本ⅴa欧美va伊人久久| 日韩欧美精品v在线| 久久久久久国产a免费观看| 欧美乱妇无乱码| 亚洲欧美精品综合久久99| 18+在线观看网站| 身体一侧抽搐| 久久精品国产清高在天天线| 天美传媒精品一区二区| xxxwww97欧美| 日韩大尺度精品在线看网址| 亚洲电影在线观看av| 国产私拍福利视频在线观看| 欧美成人a在线观看| 午夜福利成人在线免费观看| 久久久久久久久久成人| 91午夜精品亚洲一区二区三区 | 日本 av在线| 99久久无色码亚洲精品果冻| 国产单亲对白刺激| 国产在线男女| 一进一出抽搐gif免费好疼| 男女床上黄色一级片免费看| 亚洲欧美清纯卡通| 黄色丝袜av网址大全| 亚洲经典国产精华液单 | 精品午夜福利视频在线观看一区| 亚洲va日本ⅴa欧美va伊人久久| 婷婷色综合大香蕉| 国产一区二区三区在线臀色熟女| 国产精品嫩草影院av在线观看 | 能在线免费观看的黄片| 午夜久久久久精精品| 亚洲经典国产精华液单 | 99热这里只有是精品在线观看 | 久久中文看片网| 99riav亚洲国产免费| 最近最新中文字幕大全电影3| 全区人妻精品视频| 丰满人妻一区二区三区视频av| 日本 欧美在线| 一卡2卡三卡四卡精品乱码亚洲| 伊人久久精品亚洲午夜| 神马国产精品三级电影在线观看| 琪琪午夜伦伦电影理论片6080| 可以在线观看的亚洲视频| 久久久久久久亚洲中文字幕 | 亚洲七黄色美女视频| 欧美丝袜亚洲另类 | 好看av亚洲va欧美ⅴa在| 国产精品影院久久| 日韩欧美免费精品| 午夜激情福利司机影院| 国产伦精品一区二区三区四那| 一个人看的www免费观看视频| 亚洲成人精品中文字幕电影| 亚洲黑人精品在线| 日本三级黄在线观看| av福利片在线观看| 黄色女人牲交| 性色avwww在线观看| 国产色婷婷99| 亚洲国产高清在线一区二区三| 国产精品一及| 国产亚洲av嫩草精品影院| 高潮久久久久久久久久久不卡| 成人毛片a级毛片在线播放| 国产黄a三级三级三级人| 精品欧美国产一区二区三| 国产精品一区二区免费欧美| 午夜两性在线视频| 黄片小视频在线播放| 好男人在线观看高清免费视频| 免费人成在线观看视频色| 日韩成人在线观看一区二区三区| 性插视频无遮挡在线免费观看| 国产精品乱码一区二三区的特点| 天天躁日日操中文字幕| 69人妻影院| 国产成人福利小说| 久久人人爽人人爽人人片va | 亚洲av电影在线进入| 亚洲av成人av| 美女黄网站色视频| 色综合站精品国产| 床上黄色一级片| 国产高清有码在线观看视频| 日本免费a在线| 亚洲av电影在线进入| 精品免费久久久久久久清纯| 男女之事视频高清在线观看| 久久久久国内视频| 成人无遮挡网站| 亚洲精品456在线播放app | 99热这里只有是精品在线观看 | 日本熟妇午夜| 人妻制服诱惑在线中文字幕| 亚洲精品日韩av片在线观看| 国产91精品成人一区二区三区| 亚洲精品影视一区二区三区av| 亚洲最大成人手机在线| 免费观看精品视频网站| 国产免费男女视频| 嫩草影视91久久| 亚洲激情在线av| 国产成人影院久久av| 免费在线观看亚洲国产| 级片在线观看| 日韩免费av在线播放| 舔av片在线| 久久99热6这里只有精品| 欧美乱色亚洲激情| 五月伊人婷婷丁香| 少妇裸体淫交视频免费看高清| 欧美日韩福利视频一区二区| 成人美女网站在线观看视频| 小说图片视频综合网站| 国产精品久久久久久精品电影| 亚洲欧美日韩卡通动漫| 男人狂女人下面高潮的视频| 亚洲午夜理论影院| 精品人妻1区二区| 免费搜索国产男女视频| 国产美女午夜福利| 人人妻人人看人人澡| ponron亚洲| 亚洲av美国av| 亚洲成av人片免费观看| 亚洲成av人片免费观看| 性欧美人与动物交配| 免费人成在线观看视频色| 欧美+亚洲+日韩+国产| 亚洲精品粉嫩美女一区| 青草久久国产| 免费看日本二区| 亚洲中文日韩欧美视频| 国产精品一区二区性色av| 亚洲精品色激情综合| 日本一二三区视频观看| 国产av一区在线观看免费| 激情在线观看视频在线高清| 亚洲成人精品中文字幕电影| 综合色av麻豆| 亚洲人与动物交配视频| 可以在线观看毛片的网站| 大型黄色视频在线免费观看| 色哟哟·www| 如何舔出高潮| 欧美日韩黄片免| 亚洲狠狠婷婷综合久久图片| 久久久久性生活片| 亚洲无线观看免费| 亚洲国产精品999在线| 欧美黑人巨大hd| 直男gayav资源| 久久精品91蜜桃| 变态另类丝袜制服| 一级黄片播放器| 人妻制服诱惑在线中文字幕| 国产精品一及| 很黄的视频免费| 成人永久免费在线观看视频| 亚洲国产精品sss在线观看| 两个人视频免费观看高清| 又爽又黄a免费视频| 色哟哟哟哟哟哟| 噜噜噜噜噜久久久久久91| 久久久国产成人精品二区| 国产 一区 欧美 日韩| 国产伦精品一区二区三区四那| 婷婷精品国产亚洲av在线| а√天堂www在线а√下载| 中文字幕人妻熟人妻熟丝袜美| 1000部很黄的大片| 中文字幕熟女人妻在线| 中文字幕免费在线视频6| 日本熟妇午夜| www.色视频.com| 国产真实乱freesex| 免费人成在线观看视频色| 午夜免费成人在线视频| 免费大片18禁| 99热这里只有精品一区| 在线十欧美十亚洲十日本专区| 国产乱人视频| 女生性感内裤真人,穿戴方法视频| 国产人妻一区二区三区在| 啦啦啦韩国在线观看视频| 中文亚洲av片在线观看爽| 麻豆国产97在线/欧美| 成年女人毛片免费观看观看9| 在线观看舔阴道视频| 九九久久精品国产亚洲av麻豆| 午夜精品久久久久久毛片777| 亚洲国产日韩欧美精品在线观看| 3wmmmm亚洲av在线观看| 国产成人影院久久av| 真人做人爱边吃奶动态| 午夜福利欧美成人| 日日摸夜夜添夜夜添av毛片 | 精品久久久久久成人av| 欧美日韩综合久久久久久 | 国产毛片a区久久久久| 久久精品久久久久久噜噜老黄 | 亚洲国产精品合色在线| 亚洲国产欧美人成| 中文字幕精品亚洲无线码一区| 熟妇人妻久久中文字幕3abv| av国产免费在线观看| 男女视频在线观看网站免费| 观看免费一级毛片| 不卡一级毛片| 69av精品久久久久久| 久久精品国产亚洲av天美| 中文亚洲av片在线观看爽| 亚洲av日韩精品久久久久久密| x7x7x7水蜜桃| 日本黄色视频三级网站网址| 国产精品一区二区三区四区久久| 可以在线观看的亚洲视频| 国产午夜精品论理片| 久久精品久久久久久噜噜老黄 | 欧美最新免费一区二区三区 | 亚洲精品影视一区二区三区av| 看片在线看免费视频| 最好的美女福利视频网| 精品免费久久久久久久清纯| 最近最新中文字幕大全电影3| 不卡一级毛片| 亚洲aⅴ乱码一区二区在线播放| 免费黄网站久久成人精品 | 亚洲欧美日韩卡通动漫| 国产大屁股一区二区在线视频| 亚洲美女黄片视频| 欧美黑人巨大hd| 高潮久久久久久久久久久不卡| 久久久久久九九精品二区国产| 露出奶头的视频| 色av中文字幕| 午夜两性在线视频| 91在线精品国自产拍蜜月| 午夜久久久久精精品| 12—13女人毛片做爰片一| 亚洲欧美日韩卡通动漫| 又黄又爽又刺激的免费视频.| 丁香欧美五月| 免费观看的影片在线观看| av专区在线播放| 亚洲片人在线观看| 久久九九热精品免费| 国语自产精品视频在线第100页| 亚洲av成人av| 国产精品久久久久久久久免 | 日本 av在线| 又爽又黄无遮挡网站| 久久香蕉精品热| 乱人视频在线观看| 久久久久精品国产欧美久久久| 男人舔女人下体高潮全视频| 亚洲人成伊人成综合网2020| 99视频精品全部免费 在线| 九色成人免费人妻av| 亚洲av成人精品一区久久| av天堂在线播放| www.www免费av| 欧美日本视频| 久久99热这里只有精品18| 久久99热6这里只有精品| 国产亚洲精品久久久久久毛片| 麻豆国产97在线/欧美| 直男gayav资源| 99国产极品粉嫩在线观看| 国模一区二区三区四区视频| 中文字幕高清在线视频| 精品一区二区免费观看| 如何舔出高潮| 久久久久久九九精品二区国产| 欧美在线一区亚洲| 天堂av国产一区二区熟女人妻| 欧美bdsm另类| 免费在线观看亚洲国产| 国产视频一区二区在线看| 99久国产av精品| 每晚都被弄得嗷嗷叫到高潮| 一区二区三区四区激情视频 | 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 丁香欧美五月| av女优亚洲男人天堂| av福利片在线观看| av在线天堂中文字幕| 国产在视频线在精品| av欧美777| x7x7x7水蜜桃| 不卡一级毛片| 午夜精品在线福利| 亚洲欧美日韩东京热| 亚洲熟妇熟女久久| 直男gayav资源| 亚洲成人精品中文字幕电影| 麻豆国产av国片精品| 三级男女做爰猛烈吃奶摸视频| or卡值多少钱| a级一级毛片免费在线观看| 日本 av在线| 首页视频小说图片口味搜索| 91午夜精品亚洲一区二区三区 | 亚洲av熟女| 中文字幕高清在线视频| 精品乱码久久久久久99久播| 亚洲久久久久久中文字幕| 又粗又爽又猛毛片免费看| 青草久久国产| av天堂中文字幕网| 亚洲av第一区精品v没综合| 免费av观看视频| 久久人人爽人人爽人人片va | 少妇熟女aⅴ在线视频| a级毛片a级免费在线| 国产色婷婷99| 亚洲av美国av| 久久精品国产亚洲av天美| 搡老岳熟女国产| 性欧美人与动物交配| 此物有八面人人有两片| 国产亚洲精品久久久com| 在线观看免费视频日本深夜| 亚洲欧美日韩卡通动漫| 色5月婷婷丁香| 听说在线观看完整版免费高清| 脱女人内裤的视频| 香蕉av资源在线| 国产精品久久电影中文字幕| 深夜a级毛片| 亚洲成a人片在线一区二区| 日韩人妻高清精品专区| 禁无遮挡网站| 国产亚洲精品久久久久久毛片| 性插视频无遮挡在线免费观看| 日本熟妇午夜| 少妇裸体淫交视频免费看高清| 国产精品亚洲美女久久久| 久久久久久大精品| 国产探花在线观看一区二区| 久久人人爽人人爽人人片va | 少妇高潮的动态图| 免费观看人在逋| 99久久99久久久精品蜜桃| 九九热线精品视视频播放| 国产伦精品一区二区三区四那| 久久久精品欧美日韩精品| 国产伦一二天堂av在线观看| 国产黄色小视频在线观看| 欧美+日韩+精品| 日韩欧美免费精品| 一本综合久久免费| 一区二区三区四区激情视频 | 亚洲中文字幕日韩| 久久九九热精品免费| 国产极品精品免费视频能看的| 久久性视频一级片| 99久久久亚洲精品蜜臀av| 精品熟女少妇八av免费久了| 国产乱人视频| 日本黄色片子视频| 国产一区二区在线观看日韩| www.熟女人妻精品国产| 国产av不卡久久| 好看av亚洲va欧美ⅴa在|